慢性阻塞性肺病患者中各种营养补充剂的影响:一个网络元分析
Jia Zeng1, Jing Cheng1, Liangdong Zhu2
1The First Affiliated Hospital of Guangzhou Medical University, No. 151 Yanjiang West Road, Guangzhou City, Guangdong, Yuexiu District, China.
BMC pulmonary medicine
|May 9, 2025
概括
这一网络元分析发现,包括纳米库尔库,丁酸盐和益生菌在内的几个营养补充剂,在慢性阻塞性肺病 (COPD) 患者中显著改善了肺功能. 其他补充剂,如黑素和Yam-Epimedium显示改善生活质量和减少呼吸障碍的承诺.
科学领域:
- 肺部医学 肺部医学
- 营养科学 营养科学
- 基于证据的医学基于证据的医学.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种进展性呼吸道疾病,具有显著的发病率和死亡率.
- 营养状况在COPD管理中起着至关重要的作用,各种补充剂正在探索治疗益处.
研究的目的:
- 系统地评估各种营养补充剂作为COPD诊断患者的干预措施的有效性.
- 使用网络元分析,比较不同补充剂的相对有效性.
主要方法:
- 在主要数据库 (PubMed,Embase,Cochrane图书馆,Web of Science) 进行了全面的文献搜索,以查询到2025年3月24日的随机对照试验.
- 使用GRADE指南评估了偏见风险和证据确定性.
- 使用R软件进行了网络元分析,以合成数据并比较干预措施.
主要成果:
- 分析了37项研究,包括1975名COPD患者和21种补充剂.
- 纳米库尔库,丁酸盐和益生菌显著改善了1秒内强迫呼气量 (FEV1).
- 辅酶Q10与肌酸,氨酸 (MLT),酸盐和乳清蛋白一起增强了运动耐力 (6分钟的步行距离).
- 通过MLT和Yam-Epimedium减少呼吸障碍 (mMRC得分).
- MLT,维生素D (VD) 和乳清蛋白改善了生活质量 (CAT分数).
- Yam-Epimedium,肌酸和AKL1改善了呼吸系统的生活质量 (SGRQ分数).
结论:
- 各种营养补充剂对COPD患者有潜在的益处,具有不同的疗效水平.
- 纳米似乎对肺功能最有效,而辅酶Q10与肌酸在运动耐力方面表现出色.
- Yam-Epimedium和MLT在减少呼吸障碍和改善COPD管理中的生活质量方面显示出显著的希望.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K


